Published in Tumour Biol on July 20, 2013
Aromatase expression and regulation in breast and endometrial cancer. J Mol Endocrinol (2016) 0.77
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62
Two pathogenetic types of endometrial carcinoma. Gynecol Oncol (1983) 6.26
Endometrial carcinoma. N Engl J Med (1996) 3.31
Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology (1996) 2.30
Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Proc Natl Acad Sci U S A (2000) 1.97
The epidemiology of endometrial cancer. Gynecol Oncol (1991) 1.94
Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst (1996) 1.76
Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.75
The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol (2003) 1.59
Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study. Am J Obstet Gynecol (2008) 1.52
Influence of body mass index on prognosis in gynecological malignancies. Cancer Causes Control (2008) 1.30
Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer (2001) 1.23
Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol (2005) 1.12
G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua. Mol Hum Reprod (2010) 1.12
Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur J Cancer (2011) 1.10
Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer. Mol Cell Endocrinol (2008) 1.07
Aromatase excess in cancers of breast, endometrium and ovary. J Steroid Biochem Mol Biol (2007) 1.06
Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease. Mol Cell Endocrinol (2011) 1.01
Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Am J Pathol (1995) 0.97
Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome. Br J Cancer (2012) 0.96
Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression. Oncogene (2001) 0.94
The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2. Endocr Relat Cancer (1999) 0.93
Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis. Am J Obstet Gynecol (2005) 0.92
Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation. Gynecol Oncol (2011) 0.91
Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium. Jpn J Cancer Res (2000) 0.89
Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction. Endocr Relat Cancer (2008) 0.88
Expression of aromatase, estrogen receptors, and their coactivators in patients with endometrial cancer. Fertil Steril (2006) 0.82
Aromatase expression in stromal cells of endometrioid endometrial cancer correlates with poor survival. Clin Cancer Res (2005) 0.82
Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. Gynecol Oncol (2005) 0.81
Surgery followed by radiotherapy in endometrial cancer: analysis of survival and patterns of failure. Int J Gynecol Cancer (1999) 0.80
Is aromatase cytochrome P450 involved in the pathogenesis of endometrioid endometrial cancer? Int J Gynecol Cancer (2005) 0.79
Expression of estrogen receptors (α, β), cyclooxygenase-2 and aromatase in normal endometrium and endometrioid cancer of uterus. Adv Med Sci (2013) 0.79
Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet (2006) 3.16
Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res (2006) 2.41
A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Clin Endocrinol Metab (2009) 1.32
Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol (2005) 1.20
Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol (2005) 1.15
Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis. Hum Mutat (2007) 1.13
Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors. Eur J Cancer (2005) 1.09
Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein in breast cancer. Oncol Rep (2005) 1.03
Alterations in connexin26 expression during colorectal carcinogenesis. Oncology (2005) 1.00
The significance of the expression of ERRalpha as a potential biomarker in breast cancer. J Steroid Biochem Mol Biol (2008) 0.99
Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer. Pathol Oncol Res (2007) 0.97
Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. Int J Mol Med (2003) 0.96
Prenatally evolving ectopia cordis with successful surgical treatment. Fetal Diagn Ther (2011) 0.95
Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod (2007) 0.95
Leptin--from regulation of fat metabolism to stimulation of breast cancer growth. Pathol Oncol Res (2006) 0.94
Human cultured skin fibroblasts express estrogen receptor alpha and beta. Int J Mol Med (2002) 0.94
Expression of connexins 26, 32 and 43 in the human colon--an immunohistochemical study. Folia Histochem Cytobiol (2004) 0.91
Expression of connexin 43 in breast cancer in comparison with mammary dysplasia and the normal mammary gland. Folia Morphol (Warsz) (2003) 0.89
Comparative evaluation of estrogen and progesterone receptor expression with connexins 26 and 43 in endometrial cancer. Int J Gynecol Cancer (2009) 0.89
The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients. J Clin Endocrinol Metab (2014) 0.89
STAT1 and STAT3 as intracellular regulators of vascular remodeling. Eur J Intern Med (2007) 0.88
Increased expression of gap junction protein--connexin 32 in lymph node metastases of human ductal breast cancer. Folia Histochem Cytobiol (2007) 0.88
Patterns of infertility in Poland - multicenter study. Neuro Endocrinol Lett (2011) 0.87
[The impact of illness on the emotional life of women united in "the amazons" clubs after breast cancer surgery]. Ann Acad Med Stetin (2009) 0.87
Serum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome. Diabetes (2010) 0.86
Significant coexpression of GLUT-1, Bcl-xL, and Bax in colorectal cancer. Ann N Y Acad Sci (2007) 0.86
Relations of TGF-beta1 with HIF-1 alpha, GLUT-1 and longer survival of colorectal cancer patients. Pathology (2009) 0.86
Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells. Int J Cancer (2009) 0.85
The frequency of CD25+CD4+ and FOXP3+ regulatory T cells in ectopic endometrium and ectopic decidua. Reprod Biol Endocrinol (2010) 0.85
Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab (2004) 0.85
Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer. World J Gastroenterol (2005) 0.85
Transforming growth factor-beta1 and regulators of apoptosis. Ann N Y Acad Sci (2009) 0.84
A case of complete hypogonadotropic hypogonadism with a mutation in the gonadotropin-releasing hormone receptor gene. Fertil Steril (2003) 0.83
Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer. World J Gastroenterol (2005) 0.83
[The role of vitamin D in the carcinogenesis of breast and ovarian cancer]. Ginekol Pol (2013) 0.82
Primary amenorrhea in a young Polish woman with complete androgen insensitivity syndrome and Sertoli-Leydig cell tumor: identification of a new androgen receptor gene mutation and evidence of aromatase hyperactivity and apoptosis dysregulation within the tumor. Gynecol Endocrinol (2007) 0.82
Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma. Ann N Y Acad Sci (2006) 0.82
Erythropoietin and erythropoietin receptor in colorectal cancer. Int J Surg Pathol (2008) 0.81
Cumulative expression of HIF-1-alpha, Bax, Bcl-xL and P53 in human colorectal cancer. Pathology (2007) 0.81
Insulin-like growth factor-I receptor correlates with connexin 26 and Bcl-xL expression in human colorectal cancer. Ann N Y Acad Sci (2006) 0.81
Elevation of sE-Selectin Levels 2-24 Months following Gestational Diabetes Is Associated with Early Cardiometabolic Risk in Nondiabetic Women. Int J Endocrinol (2012) 0.81
Green tea as an antioxidant which protects against alcohol induced injury in rats -- a histopathological examination. Folia Morphol (Warsz) (2004) 0.81
[Prophylactic medical examinations for breast cancer and uterine cervix cancer in Regional Oncological Center of Bydgoszcz in year 2002]. Ginekol Pol (2003) 0.81
Differential effects of estradiol, raloxifene and tamoxifen on estrogen receptor expression in cultured human skin fibroblasts. Int J Mol Med (2004) 0.81
Expression of insulin-like growth factor-I receptor, estrogen receptor alpha, Bcl-2 and Bax proteins in human breast cancer. Oncol Rep (2005) 0.81
Potential first trimester metabolomic biomarkers of abnormal birth weight in healthy pregnancies. Prenat Diagn (2014) 0.80
The analysis of metallothionein immunoreactivity in stromal fibroblasts and macrophages in cases of uterine cervical carcinoma with respect to both the local and distant spread of the disease. Am J Reprod Immunol (2013) 0.80
[Evaluation of the efficacy and safety of Foley catheter pre-induction of labor]. Ginekol Pol (2013) 0.80
Serum irisin concentration in women with gestational diabetes. Gynecol Endocrinol (2014) 0.80
Correlation between Bcl-2 protein expression and some clinicopathological features of oral squamous cell carcinoma. Pol J Pathol (2003) 0.80
Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related? Nephrol Dial Transplant (2005) 0.80
The influence of N- and O-glycosylation inhibitors on the glycosylation profile of cellular membrane proteins and adhesive properties of carcinoma cell lines. Int J Mol Med (2006) 0.79
[Comparison of VEGF, IL-8 and beta-FGF concentrations in the serum and ascites of patients with ovarian cancer]. Ginekol Pol (2011) 0.79
Comparison of STAT3 with HIF-1alpha, Ob and ObR expressions in human endometrioid adenocarcinomas. Tissue Cell (2008) 0.79
The expression of suppressor of cytokine signaling 1 and 3 in fat and placental tissue from women with gestational diabetes. Gynecol Endocrinol (2012) 0.79
Levels of VE-cadherin increase independently of VEGF in preoperative sera of patients with colorectal cancer. Tumori (2006) 0.79
Serum anti-müllerian hormone levels in patients with epithelial ovarian cancer. Int J Endocrinol (2013) 0.79
Aberrant distributions and relationships among E-cadherin, beta-catenin, and connexin 26 and 43 in endometrioid adenocarcinomas. Int J Gynecol Pathol (2010) 0.79
Adenoid basal carcinoma-like tumor combined with invasive squamous cell carcinoma foci of uterine cervix - a case report of 55-year-old woman with literature review. Rom J Morphol Embryol (2014) 0.79
ERα and ERβ expression in correlation with Ki-67, Bcl-2 and Bak in primary tumors and lymph node metastases of breast cancer: The effect of pre-operative chemotherapy. Oncol Lett (2010) 0.78
Comparison of beta-catenin with TGF-beta1, HIF-1alpha and patients' disease-free survival in human colorectal cancer. Pathol Oncol Res (2009) 0.78
RCAS1 decidual immunoreactivity in severe pre-eclampsia: immune cell presence and activity. Am J Reprod Immunol (2007) 0.78
Expression of cell proliferation and apoptosis markers in papillomas and cancers of conjunctiva and eyelid. Ann N Y Acad Sci (2004) 0.78
Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer. Anticancer Res (2009) 0.78
STAT3, HIF-1alpha, EPO and EPOR - signaling proteins in human primary ductal breast cancers. Folia Histochem Cytobiol (2007) 0.78
[Clinical study of perinatal hysterectomy between 2000-2011 in the clinic of obstetrics, gynecological diseases and oncological gynecology in Bydgoszcz]. Ginekol Pol (2014) 0.78
Expression of estrogen receptors in the pelvic floor of pre- and post-menopausal women presenting pelvic organ prolapse. Folia Histochem Cytobiol (2011) 0.78
An evaluation of Ki-67 and PCNA expression in conjunctival and eyelid tumours. Folia Morphol (Warsz) (2004) 0.78
STAT3 and hypoxia induced proteins--HIF-1alpha, EPO and EPOR in relation with Bax and Bcl-xL in nodal metastases of ductal breast cancers. Folia Histochem Cytobiol (2009) 0.78
The DAX1 mutation in a patient with hypogonadotropic hypogonadism and adrenal hypoplasia congenita causes functional disruption of induction of spermatogenesis. J Assist Reprod Genet (2012) 0.78
IGF-IR in patients with advanced colorectal cancer in correlation with certain clinico-morphological factors: Initial report. Oncol Lett (2011) 0.78
Differences in the soluble HLA-G blood serum concentration levels in patients with ovarian cancer and ovarian and deep endometriosis. Am J Reprod Immunol (2010) 0.77
Inhibition of the O-glycan elongation limits MUC1 incorporation to cell membrane of human endometrial carcinoma cells. Int J Mol Med (2004) 0.77
The expression of transcription factor 7-like 2 (TCF7L2) in fat and placental tissue from women with gestational diabetes. Diabetes Res Clin Pract (2011) 0.77
Analysis of RCAS1 immunoreactivity within hydatidiform mole cells and decidual cells according to the applied therapeutic strategy: surgery or surgery followed by chemotherapy. Gynecol Obstet Invest (2012) 0.77
STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different estrogen receptor-α immunoprofile. Gynecol Endocrinol (2011) 0.77
Human amniotic-fluid-derived stem cells: a unique source for regenerative medicine. Expert Opin Biol Ther (2014) 0.77
GLUT1 and Bcl-xL in relation to erythropoietin in human colorectal adenocarcinomas. Hepatogastroenterology (2010) 0.77
A novel Gly to Arg substitution at position 388 of the alpha1 chain of type I collagen in lethal form of osteogenesis imperfecta. Acta Biochim Pol (2002) 0.77
Expression of connexin 26 in endometrial adenocarcinoma--analysis of correlations with some anatomoclinical features. Folia Histochem Cytobiol (2008) 0.77
[Gap junction intercellular communication in carcinogenesis of endometrial cancer]. Ginekol Pol (2011) 0.77
Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome. Endocr J (2016) 0.77
Identification of carotenoids in ovarian tissue in women. Oncol Rep (2005) 0.77
Contribution of quinolinic acid in the development of anemia in renal insufficiency. Am J Physiol Renal Physiol (2002) 0.77
Insulin resistance is associated with decreased circulating mannan-binding lectin concentrations in women with polycystic ovary syndrome. Diabetes Care (2008) 0.76
Comparative studies of osteoblast and fibroblast type I collagen in a patient with osteogenesis imperfecta type IV. J Pathol (2002) 0.76
The relationships between hypoxia-dependent markers: HIF-1alpha, EPO and EPOR in colorectal cancer. Folia Histochem Cytobiol (2013) 0.76
Tissue inhibitors of matrix metalloproteinase-1 levels are increased in serum of patients with allergic contact dermatitis. Contact Dermatitis (2007) 0.76
[Angiogenesis in the female reproductive processes]. Ginekol Pol (2004) 0.76
Aromatase gene expression in immature rat Sertoli cells: age-related changes in the FSH signalling pathway. Reprod Fertil Dev (2010) 0.76
[Comparative studies of K1-67 expression between the primary tumor and breast cancer metastases to regional lymph nodes]. Ginekol Pol (2003) 0.76